Search research articles
Contact Us
Filters
Showing results (41-50 of 76) with videos related to
Page
of 8
Sort By:
Plos One
|
August 26, 2014
Undertriage in older emergency department patients--tilting against windmills?
Florian F Grossmann, Thomas Zumbrunn, Sandro Ciprian, et al.
The American Journal of Emergency Medicine
|
July 3, 2019
Optimizing the month of the year backwards test for delirium screening of older patients in the emergency department
Wolfgang Hasemann, Florian F Grossmann, Roland Bingisser, et al.
International Journal of Radiation Oncology, Biology, Physics
|
May 1, 2016
Avoiding Severe Toxicity From Combined BRAF Inhibitor and Radiation Treatment: Consensus Guidelines from the Eastern Cooperative Oncology Group (ECOG)
Christopher J Anker, Kenneth F Grossmann, Michael B Atkins, et al.
The Review of Scientific Instruments
|
March 3, 2010
Status report of the Dresden EBIS/EBIT developments
G Zschornack, F Grossmann, U Kentsch, et al.
Internal and Emergency Medicine
|
January 1, 2018
Screening and detection of delirium in older ED patients: performance of the modified Confusion Assessment Method for the Emergency Department (mCAM-ED). A two-step tool
Wolfgang Hasemann, Florian F Grossmann, Rahel Stadler, et al.
Journal of Neurosurgery
|
March 14, 2015
Local control after stereotactic radiosurgery for brain metastases in patients with melanoma with and without BRAF mutation and treatment
David Ly, Hilary P Bagshaw, Christopher J Anker, et al.
Zeitschrift Fur Gastroenterologie
|
March 1, 1993
Interrelations between electrical and biochemical processes in ischemic porcine livers at low temperature
G Kehrer, A Aminalai, E Bürger, et al.
Cancer Medicine
|
November 3, 2019
Real-world survival of patients with advanced BRAF V600 mutated melanoma treated with front-line BRAF/MEK inhibitors, anti-PD-1 antibodies, or nivolumab/ipilimumab
Justin C Moser, Danli Chen, Siwen Hu-Lieskovan, et al.
Head & Neck
|
February 26, 2017
Treatment-related determinants of survival in early-stage (T1-2N0M0) oral cavity cancer: A population-based study
Justin C Sowder, Richard B Cannon, Luke O Buchmann, et al.
Journal of Clinical Medicine
|
December 24, 2015
Detection of Exosomal miRNAs in the Plasma of Melanoma Patients
Susan R Pfeffer, Kenneth F Grossmann, Pamela B Cassidy, et al.
Page
of 8
Search research articles
Search
Showing results (41-50 of 76) with videos related to
Sort By:
Page
of 8
Plos One
|
August 26, 2014
Undertriage in older emergency department patients--tilting against windmills?
Florian F Grossmann, Thomas Zumbrunn, Sandro Ciprian, et al.
The American Journal of Emergency Medicine
|
July 3, 2019
Optimizing the month of the year backwards test for delirium screening of older patients in the emergency department
Wolfgang Hasemann, Florian F Grossmann, Roland Bingisser, et al.
International Journal of Radiation Oncology, Biology, Physics
|
May 1, 2016
Avoiding Severe Toxicity From Combined BRAF Inhibitor and Radiation Treatment: Consensus Guidelines from the Eastern Cooperative Oncology Group (ECOG)
Christopher J Anker, Kenneth F Grossmann, Michael B Atkins, et al.
The Review of Scientific Instruments
|
March 3, 2010
Status report of the Dresden EBIS/EBIT developments
G Zschornack, F Grossmann, U Kentsch, et al.
Internal and Emergency Medicine
|
January 1, 2018
Screening and detection of delirium in older ED patients: performance of the modified Confusion Assessment Method for the Emergency Department (mCAM-ED). A two-step tool
Wolfgang Hasemann, Florian F Grossmann, Rahel Stadler, et al.
Journal of Neurosurgery
|
March 14, 2015
Local control after stereotactic radiosurgery for brain metastases in patients with melanoma with and without BRAF mutation and treatment
David Ly, Hilary P Bagshaw, Christopher J Anker, et al.
Zeitschrift Fur Gastroenterologie
|
March 1, 1993
Interrelations between electrical and biochemical processes in ischemic porcine livers at low temperature
G Kehrer, A Aminalai, E Bürger, et al.
Cancer Medicine
|
November 3, 2019
Real-world survival of patients with advanced BRAF V600 mutated melanoma treated with front-line BRAF/MEK inhibitors, anti-PD-1 antibodies, or nivolumab/ipilimumab
Justin C Moser, Danli Chen, Siwen Hu-Lieskovan, et al.
Head & Neck
|
February 26, 2017
Treatment-related determinants of survival in early-stage (T1-2N0M0) oral cavity cancer: A population-based study
Justin C Sowder, Richard B Cannon, Luke O Buchmann, et al.
Journal of Clinical Medicine
|
December 24, 2015
Detection of Exosomal miRNAs in the Plasma of Melanoma Patients
Susan R Pfeffer, Kenneth F Grossmann, Pamela B Cassidy, et al.
Page
of 8